| PERIOD ENDING | 28-Mar-09 | 27-Dec-08 | 27-Sep-08 | 28-Jun-08 | | Total Revenue | 1,195,107 | 1,419,264 | 1,703,579 | 1,903,253 | | Cost of Revenue | 1,126,517 | 1,335,466 | 1,572,688 | 1,763,612 | | | Gross Profit | 68,590 | 83,798 | 130,891 | 139,641 | | | Operating Expenses | | Research Development | 4,720 | 4,192 | 4,815 | 5,872 | | Selling General and Administrative | 57,055 | 62,987 | 71,206 | 77,425 | | Non Recurring | 18,958 | 13,033 | 495,321 | 14,956 | | Others | 1,023 | 1,650 | 1,650 | 1,650 | | | | Total Operating Expenses | 81,756 | 81,862 | 572,992 | 99,903 | | | | Operating Income or Loss | (13,166) | 1,936 | (442,101) | 39,738 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,752 | 4,003 | 515 | 9,467 | | Earnings Before Interest And Taxes | (6,414) | 5,939 | (441,586) | 49,205 | | Interest Expense | 28,112 | 29,183 | 30,296 | 29,961 | | Income Before Tax | (34,526) | (23,244) | (471,882) | 19,244 | | Income Tax Expense | 3,012 | 2,029 | 2,033 | 7,275 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (37,538) | (25,273) | (473,915) | 11,969 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (11,264) | 3,359 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (37,538) | (25,273) | (485,179) | 15,328 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($37,538) | ($25,273) | ($485,179) | $15,328 |
|
0.45% Nasdaq 
0.20%
Income Statement
